The global immunohematology market is expected to reach USD 3.58 billion by 2028, at a CAGR of 5.92% from 2021 to 2028.

NEWARK, UNITED STATES, NEW JERSEY, November 3, 2021 /EINPresswire.com/ -- As per the report published by The Brainy Insights, the global immunohematology market is expected to reach USD 3.58 billion by 2028, at a CAGR of 5.92% from 2021 to 2028.North America is accounted for the highest market value of USD 727.46 million in 2020. The main reason is that this region, especially in the US, is having the most advanced healthcare infrastructure in the world and government with big players are also taking initiatives for the investment in R&D for better facilities and working of Blood bank. Europe held the second-highest market value of USD 610.71 million in 2020. This is due to the better infrastructure in the region and more awareness among the people.

Key players operating in the global Immunohematology market include Siemens Healthcare GmbH, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Grifols, Immucor, Abbott laboratories, Beckman Coulter, ThermoFisher, Becton Dickinson and Merck KGaA among others.The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances and partnerships to improve their market position in the global immunohematology industry. For instance, FDA clears ORTHO Sera ID-MTS for use on the ORTHO VISION Analyzer, fully automated technology from ortho clinical diagnostics aids in extended antigen phenotyping and ensures delivery of safe blood to transfusion Patients.

Get Free Sample Report: https://www.thebrainyinsights.com/enquiry/sample-request/12544

The product segment is divided into reagents and analyzers. Reagents segment is accounted for the highest market value of USD 1.32 Billion in 2020. The technological advancement in this market has led to many new diagnostic approaches like the vitro study, which is the blood compatibility study of donor and receiver. The big players are working on improving the safety and the longevity of the blood stored in the blood bank with the advancement in immunohematology devices. The application segment includes pretransfusion testing, investigation of immune hemolysis, perinatal testing, blood group phenotyping / genotyping and leucocyte and platelet serology. The Investigation of immune hemolysis accounts for 28.28% of market share in 2020. The disease segment includes blood-related diseases, HIV and hepatitis. The HIV segment accounted for the highest market value of USD 797.43 Million in 2020. Immunohematology is the study of antigens in blood cells and antibodies in the plasma. It aids in the reduction of transfusion-related fatalities, such as HIV and thalassemia.

The end-user segment includes hospitals, blood banks and diagnostic laboratories. The hospital segment is expected to have the highest market share of around 39.23% in 2020. This is due to the great demand for immunohematology devices in the hospital.

There is a huge investment needed by the company in the R&D and technology department in order to come up with a new solution. However, a surge in the number of blood donors, blood banks, and blood collection events in high-income countries are likely to contribute its substantial share in the growth of the immunohematology market in the upcoming years.

Get Full Access to Report: https://www.thebrainyinsights.com/report/immunohematology-market-12544

Customization of the Report:
The customization of this report is available as per the client’s need. The report can be customized according to your requirements. We consistently update our research offerings to provide our clients with the latest trends in the market. For customization and to know more about this business report, please contact our sales team at sales@thebrainyinsights.com or +1-315-215-1633. Our sales executives will ensure that you can get a report that fulfills your requirements and suits your needs.

About Us
The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients' objectives of high-quality output within a short span of time. We provide both customized (clients' specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients' requirement whether they are looking to expand or planning to launch a new product in the global market.

Contact Us

Mark Stone
The Brainy Insights
+1 315-215-1633
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.